Grant: Project Grant
McGill University
$302,174.00
Psychological and biological determinants of opioid craving among chronic pain patients prescribed opioid therapy
EF 2017-18
Résumé
The use of opioids for patients with chronic pain has increased exponentially within the past decade. This has been accompanied by dramatic increases in rates of prescription opioid misuse, opioid addiction, and opioid-related overdose deaths in these patients. Recent research indicates that opioid craving (i.e., the subjective desire to consume opioids) is one of the strongest factors that contribute to the misuse of opioids. To date, however, little is known on the factors that are responsible for opioid craving in patients with chronic pain. Studies have shown that patients do not crave opioids simply because they experience high levels of pain. Although psychological factors such as negative affect might contribute to opioid craving, there is reason to believe that biological factors such as central nervous system (CNS) abnormalities and hypothalamic-pituitary-adrenal (HPA) axis dysfunctions might also contribute to opioid craving in patients with pain. The overarching goal of this research is to better understand the psychological and biological determinants of opioid craving among patients with chronic pain. In this research, we will recruit 100 adult patients with chronic pain who are prescribed opioids as part of their care at the Pain Management Unit (PMU) of the Montreal General Hospital. Patients will first undergo procedures assessing CNS abnormalities in a laboratory setting. Patients will then be asked to complete electronic questionnaires and provide saliva samples over a 10-day period, at home, to assess psychological factors, opioid craving, and HPA axis (i.e., cortisol) activity. Analyses will examine the influence of psychological and biological factors on opioid craving. Findings from our research will help better understand why patients with may crave their opioids. Our findings could also lead to new treatment interventions to reduce prescription opioid craving and, in turn, rates of opioid misuse among the Canadian population.
Programme
Project Grant
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
372609
Name
Martel Marc Olivier
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Behavioural Sciences - B: Clinical Behavioural Sciences
Projecttitle
Psychological and biological determinants of opioid craving among chronic pain patients prescribed opioid therapy
Programtype2
Operating Grants
Orgnameinp2
McGill University
Cihramount2
$302,174
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Chronic Pain; Neuroendocrine Factors; Opioid Craving; Opioid Misuse & Addiction; Opioids; Psychological Factors
Abstract
The use of opioids for patients with chronic pain has increased exponentially within the past decade. This has been accompanied by dramatic increases in rates of prescription opioid misuse, opioid addiction, and opioid-related overdose deaths in these patients. Recent research indicates that opioid craving (i.e., the subjective desire to consume opioids) is one of the strongest factors that contribute to the misuse of opioids. To date, however, little is known on the factors that are responsible for opioid craving in patients with chronic pain. Studies have shown that patients do not crave opioids simply because they experience high levels of pain. Although psychological factors such as negative affect might contribute to opioid craving, there is reason to believe that biological factors such as central nervous system (CNS) abnormalities and hypothalamic-pituitary-adrenal (HPA) axis dysfunctions might also contribute to opioid craving in patients with pain. The overarching goal of this research is to better understand the psychological and biological determinants of opioid craving among patients with chronic pain. In this research, we will recruit 100 adult patients with chronic pain who are prescribed opioids as part of their care at the Pain Management Unit (PMU) of the Montreal General Hospital. Patients will first undergo procedures assessing CNS abnormalities in a laboratory setting. Patients will then be asked to complete electronic questionnaires and provide saliva samples over a 10-day period, at home, to assess psychological factors, opioid craving, and HPA axis (i.e., cortisol) activity. Analyses will examine the influence of psychological and biological factors on opioid craving. Findings from our research will help better understand why patients with may crave their opioids. Our findings could also lead to new treatment interventions to reduce prescription opioid craving and, in turn, rates of opioid misuse among the Canadian population.
Competitiondate
201709
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Martel, Marc Olivier
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $302,174~ $0~